Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History

Long Corridor Asset Management LTD

$187 Million
Q3 2025

A detailed history of Long Corridor Asset Management LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Long Corridor Asset Management LTD holds 9,900 shares of BGNE stock, worth $2.24 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares

9,900

Previous 37,000 73.24%

Holding current value

$2.24 Million

Previous $8.39 Million 73.25%

% of portfolio

1.2%

Previous 6.48%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	N/A	-27,100 Reduced 73.24%	9,900 $2.24 Million
Q1 2025 May 12, 2025	BUY	$175.1 - $226.71 $3.26 Million - $4.22 Million	18,600 Added 101.09%	37,000 $8.39 Million
Q4 2024 Feb 11, 2025	SELL	$174.72 - $246.04 $1.29 Million - $1.81 Million	-7,355 Reduced 28.56%	18,400 $3.4 Million
Q3 2024 Nov 12, 2024	SELL	$143.93 - $224.51 $3.87 Million - $6.03 Million	-26,868 Reduced 51.06%	25,755 $5.78 Million
Q2 2024 Aug 12, 2024	BUY	$129.52 - $174.32 $5.51 Million - $7.42 Million	42,577 Added 423.82%	52,623 $7.51 Million

Q1 2024 May 13, 2024	BUY	$141.8 - $181.47 $1.42 Million - $1.82 Million	10,046 New	10,046 $1.57 Million
Q3 2023 Oct 30, 2023	BUY	$179.87 - $225.13 $85,797 - $107,387	477 Added 10.77%	4,907 $882,000
Q4 2022 Feb 13, 2023	SELL	$125.51 - $229.3 $1.15 Million - $2.1 Million	-9,170 Reduced 67.43%	4,430 $974,000
Q1 2022 Apr 25, 2022	BUY	$146.52 - $269.56 $527,472 - $970,416	3,600 Added 36.0%	13,600 $2.57 Million
Q4 2021 Feb 09, 2022	BUY	$248.56 - $389.34 $2.49 Million - $3.89 Million	10,000 New	10,000 $2.71 Million
Q3 2021 Nov 12, 2021	SELL	$249.6 - $403.14 $7.99 Million - $12.9 Million	-32,000 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$260.64 - $382.12 $5.88 Million - $8.62 Million	-22,571 Reduced 41.36%	32,000 $11.1 Million
Q4 2020 Feb 16, 2021	BUY	$221.31 - $316.61 $12.1 Million - $17.3 Million	54,571 New	54,571 $14.1 Million

Others Institutions Holding BGNE

# of Institutions

298

Shares Held

30.4M

Call Options Held

147K

Put Options Held

195K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Corridor Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Long Corridor Asset Management LTD with notifications on news.

Account

Long Corridor Asset Management LTD Bei Gene, Ltd. Transaction History